Electrochemotherapy is a treatment modality which has been increasingly used in veterinary and 23 human medicine for treating cutaneous and subcutaneous tumors. In this prospective work we 24 evaluated the outcome of using electrochemotherapy as a first-line treatment for canine oral 33 Median overall survival of patients in stage I was 16.5 months, in stage II was 9 months, in stage III 34 7.5 months, and in stage IV 4.5 months. The average number of electrochemotherapy sessions was 35 1.5 for every stage. The incidence of new metastases among treated patients was 28.4%. Patients in 36 advanced stages, with bone involvement, and caudal location of the tumor had poorer response rates 37 and shorter overall survival times. The treatment greatly improved the quality of life of the patients.
2 25 melanoma in different stages, with the aim of determining predictive factors of response to the 26 treatment. Mucosal melanoma is the most common cause of oral cancer in dogs. Canine oral 27 malignant melanoma is very similar to human oral melanoma in many aspects, being a very good 28 translational model for studying response to this treatment. Sixty-seven canine patients were treated.
29
Intravenous bleomycin was the preferred drug, and the standard operating procedures for 30 electrochemotherapy were followed. The patients were followed-up for two years. According to WHO 31 criteria, the objective response per stage was: stage I 100%, stage II 89.5%, stage III 57.7% and, 32 stage IV 36.4%. The overall median survival was 7.5 months (2-30 months, mean 9.1 months).
Introduction

42
Spontaneous tumors in dogs have many advantages as a human model of disease, they develop in the 43 presence of an intact immune system through the exposure to the same carcinogens [1] . Human and 44 canine malignant melanoma share many histological characteristics such as expression of melanocyte 45 differentiation antigens, melanocyte morphology, patterns of growth necrosis and ulceration. Both 46 have propensity to metastasize to regional lymph nodes and brain as to other organs [2] . They are suitable for preclinical trials, as the tumors evolve naturally and are very heterogeneous, making the 48 results easier to translate into human medicine. Provided the treatment studied renders good results, 49 there is a benefit for patients and owners. Kaplan-Meier curves of survival were significantly different in all groups (p<0.05). See Fig. 1 .
129
The overall median survival in all stages was 7.5 months (2-30 months, mean 9.1 months). 
149
Bone involvement determined by radiology and/or CT scan, was present in 64.2 % of the patients.
150
The most common histological subtype with bone involvement was anaplastic, followed by mixed 151 and spindle cells.
153
Overall survival in patients with bone involvement was lower, with a median of 3 months (2-18 154 months, mean 5.6 months) than in patients without bone involvement, with a median of 11.5 months
155
(4-30 months, mean 14.3 months). Kaplan-Meier curves show that the difference is statistically 
192
Due to the fact that the lesions were located in the oral cavity, many symptoms that affected the In this study, we describe the largest group of dogs with oral malignant melanoma treated with 208 electrochemotherapy with a 2-year follow-up with the aim of not only providing results of a 209 veterinarian study but of a translational study [21] , as canine oral melanomas share many 210 resemblances with human melanomas and are considered a very good preclinical model [22] .
212
The frequency of breeds, no differences in gender predisposition and age at the diagnosis are in 
216
Most of the patients in this study were in stage II or III. We believe that this is because the owner was 
225
The most frequent rostral location of the melanoma makes it easier for the owner to detect it and seek 226 for advice. This delay in the visit provided more time for the bone invasion to occur and makes it 227 more prone to metastasize for the same reason.
228
In our study, melanomas located in the tongue are rare as reported by other authors [26] . 
249
If we consider patients in stage II, and analyze the response with and without local involvement, we 250 observe that patients without bone involvement had a better local response (100% OR vs 81.8% OR, 251 without and with bone involvement respectively). Therefore, we suggest that bone involvement is an 252 important factor to take into account for treatment selection and consider the limitations of ECT for 253 these cases. Additional data is needed to confirm this hypothesis.
255
In human TNM staging for mucosal melanoma, bone or cartilage invasion is T4 regardless of the size 256 of the lesion[32]. If we apply this criterion, all the patients with bone involvement will be staged as 257 IV. In this work, we found that the local response and survival times of patients in stage III were 258 similar to the patients with bone invasion, and for that reason, we consider that patients with bone 259 invasion should be staged as III, regardless of the size of the lesion.
11 261
Overall survival of the patients varied according to the stage as it was expected. We believe that this is 262 related not only to the disease but to the effectiveness of electrochemotherapy in each stage. As a local 263 treatment, best results are obtained when no dissemination is present. Also, smaller lesions can be 264 treated more easily and covered by the 6-needle electrode. Bigger lesions may present a necrotic 265 center or may have poorly irrigated areas leading to a poor distribution of the drug in the tumor.
266
In relation to lymph node involvement, many patients with lymph nodes that were normal to palpation 267 were positive in fine needle aspiration samples. In these cases, good local response was obtained with 268 a stable systemic response. Nevertheless, patients with enlarged lymph nodes were subjected to 269 lymphadenectomy after electrochemotherapy to improve their quality of life.
270
When euthanasia is possible, the survival time of the patient is highly influenced by the quality of life.
271
In more advanced stages of the disease, there is a serious commitment to improve the quality of life of 272 the patients; since achieving this will prolong survival.
273
The average number of ECT sessions, until a steady response was reached, was 1.5 (range 1 to 4),
274
regardless of the stage. This result was not anticipated, rather we were expecting to have an average of 275 more sessions in more advanced stages, but survival time may not allow to perform more sessions.
276
Factors that we consider influence the number of sessions are: without lymph node involvement are grouped. If we analyze local response with and without lymph 291 node involvement, they seem to be very similar. In fact, in our work, patients with lymph node 292 involvement had better responses. Because of this, we believe that tumor size is more important than 293 lymph node involvement for predicting the response to electrochemotherapy, and lesions of less than 294 4 cm in diameter yield the best results when no metastases are present.
295
In our study, the incidence of metastasis was lower than in other studies. Patients in stage I did not 296 develop new metastases probably due to local control of the disease early in its course. We observed 297 that bone involvement was present in most of the patients that later developed new metastases. This 298 could be due to the difficulty in treating the invaded bone, and thus this untreated area could lead to a 299 dissemination of tumoral cells later on the progression of the disease. Also, caudal location is in 300 general more difficult to reach and to cover it adequately with the electrodes. Finally, the anaplastic 301 histological subtype was more correlated with the development of new metastases, but in this case, 302 this could be due to the higher aggressiveness of this histological subtype.
303
As mentioned before, the quality of life of the patients is very important, and poor quality of life is an 
Patients and Methods
404
In the present study, 67 canine patients were enrolled in this ECT protocol for oral mucosal 
414
Among the patients, 11 were in stage I, 19 in stage II, 26 in stage III and 11 in stage IV. The age of 415 the patients ranged from 6 to 16 months, with an average of 11.7 months. There were 37 males and 30 416 females. The most common breeds were: cross-breed, Labrador retriever, cocker and golden retriever.
418
The response to the treatment was evaluated according to WHO criteria.
419
All the regulations from the Consejo Profesional de Medicos Veterinarios were followed. Informed x-rays were performed to determine the development of lung metastases or when symptoms appeared.
450
As lymph nodes and lungs are the most common sites of metastatic dissemination [59] . 
